Research Analysts’ Weekly Ratings Updates for DocGo (DCGO)

DocGo (NASDAQ: DCGO) recently received a number of ratings updates from brokerages and research firms:

• 3/25/2026 – DocGo had its price target lowered by Canaccord Genuity Group Inc. from $1.50 to $1.00. They now have a “hold” rating on the stock.
• 3/17/2026 – DocGo had its price target lowered by Stifel Nicolaus from $4.00 to $2.50. They now have a “buy” rating on the stock.
• 3/17/2026 – DocGo had its “overweight” rating reaffirmed by Cantor Fitzgerald. They now have a $3.00 price target on the stock.
• 3/17/2026 – DocGo had its “buy” rating reaffirmed by Needham & Company LLC. They now have a $3.00 price target on the stock.

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.